US Stocks
/
CervoMed Inc. Share Price
CervoMed Inc. Share Price

CervoMed Inc. Share Price

NASDAQ: CRVO | Micro Cap
$2.45
-$0.11 (-4.3%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CervoMed Inc. Stock Performance

Open
$2.50
Prev. Close
$2.56
Circuit Range
N/A
Day Range
$2.48 - $2.50
Year Range
$2.22 - $9.92
Volume
3,014
Average Traded
$2.50

CervoMed Inc. Share Price Today

As of 19 September 2026, CervoMed Inc.'s share price is $2.45. The stock opened at $2.50, compared to its previous close of $2.56. During today's trading session, CervoMed Inc.'s share price traded between $2.48 and $2.50, with an average price of $2.49. Over the past 52 weeks, the stock has recorded a high of $9.92 and a low of $2.22. In terms of performance, CervoMed Inc.'s share price has declined by 36.20% over the last six months and is down 69.64% on a year-on-year basis.

CervoMed Inc. Share Price Chart

$2.48$2.50
L
Show Current Price
H

CervoMed Inc. Stock Fundamentals & Key Indicators

Market Cap
$22.15M
PE Ratio (TTM)
-0.82
Dividend Yield
N/A
EPS (TTM)
$-2.98
Revenue (TTM)
$4.01M
Return On Equity (TTM)
-147.98%
Profit Margin
-673.06%
Debt to Equity
0.26
Quarterly Earnings Growth YoY
-62.54%

CervoMed Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Revenue$2.35M$3.29M$1.94M$1.92M$1.76M$322569.00
Net Profit-$2.51M-$2.32M-$4.75M-$4.89M-$6.26M-$7.73M
Net Profit Margin-107.12%-70.44%-245.06%-255.23%-356.05%-2395.34%
Income ChangeN/A7.85%-105.17%-2.96%-27.88%-23.46%

CervoMed Inc. Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$7.14M$9.74M$4.01M
Net Profit-$2.17M-$16.29M-$26.97M
Net Profit Margin-30.40%-167.29%-673.06%
Income ChangeN/A-650.08%-65.53%

About CervoMed Inc.

CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in DLB and certain other major neurological disorders. It is being evaluated in a Phase 2b study in patients with DLB. The company develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.

CervoMed Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$2.63
$2.48
-6.60%
Aug 2026
$2.62
$2.65
+2.32%
Jul 2026
$3.27
$2.59
-16.85%
Jun 2026
$3.02
$3.12
-0.16%
May 2026
$3.72
$3.12
-16.13%
Apr 2026
$4.25
$3.72
-3.12%
Mar 2026
$3.77
$3.84
-3.40%
Feb 2026
$5.09
$3.98
-21.75%
Jan 2026
$7.75
$5.08
-35.04%
Dec 2025
$9.61
$7.82
-21.17%
Nov 2025
$7.12
$9.92
+39.72%
Oct 2025
$8.13
$7.10
-12.02%

CRVO Share Price FAQs

What is CervoMed Inc. share price today?

chevron-up
CervoMed Inc. share price today is $2.45 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of CervoMed Inc. stock?

chevron-up
The 52 week high of CervoMed Inc. stock is $9.92, while the 52 week low is $2.22 as of 19 Sep '26.

What is CRVO's market capitalisation today?

chevron-up
CRVO market capitalisation is $22.15M as of September 19, 2026, at 7:43 am IST.

What is CRVO's net income for the last quarter?

chevron-up
CRVO's net income for the last quarter is -0.01B USD.

What is the 5 year returns of CRVO?

chevron-up
The 5 year returns of CRVO is -93.57% as on 19 Sep '26.

What is the high & low stock price of CRVO today?

chevron-up
CRVO stock price hit a high of $2.50 and low of $2.48 as of 19 Sep '26.

Can I buy CRVO shares in India?

chevron-up
Yes. You can buy CRVO in India by opening an international trading account.